Tag: Novo Nordisk A/S

June 13, 2026

Novo Nordisk and Eli Lilly Dominance Under Threat as Drugmakers Bet Big on Obesity Treatment

April 12, 2026

GLP-1 Drugs Could Boost Apparel Retail Spending by $13 Billion Annually

February 24, 2026

Ukraine & Russia: War Fuels Dramatic Drop in Birth Rates & Fears for Future

February 8, 2026

Hims & Hers Pulls Copycat Wegovy Pill Amid Legal Threats & FDA Action

February 6, 2026

Trump Launches TrumpRx: Will New Website Lower Drug Costs?

February 5, 2026

Lilly Outpaces Novo Nordisk in Obesity Drug Market: 2026 Outlook

February 4, 2026

Eli Lilly Blows Past Estimates as Zepbound & Mounjaro Demand Soars

February 4, 2026

S&P 500 Flat as Tech Stocks Fall, Jobs Data Disappoints – Feb 4, 2026

February 3, 2026

Stock Market Today: Nvidia, Eli Lilly, Novo Nordisk & Earnings Preview

February 3, 2026

Novo Nordisk Stock Drops as Sales Forecast Declines Amid Competition

January 17, 2026

Novo Nordisk Shares Rise: Wegovy Obesity Pill Launch Success

January 12, 2026

Amazon Pharmacy Now Offers Wegovy Weight Loss Pill

January 10, 2026

Obesity Pills 2026: Novo Nordisk & Eli Lilly Lead the Way

January 9, 2026

Abivax Stock Surge: Biotech Takeover Target

January 1, 2026

Novo Nordisk Wegovy Ozempic 2026 Legal Battle

December 30, 2025

Trump’s 2025 Wall Street Deals: Tariffs & Uncertainty Slow M&A